Home -> Law Blog Directory -> Personal Injury Law Blogs -> New York City Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: New York City Personal Injury LawyerClinical Trials Funded by Pharmaceutical Industry more likely to Report Positive Results
By Paul Napoli
August 2, 2010
A study of clinical drug trials found that those funded by the pharmaceutical industry were more likely to report positive outcomes than were trials funded by other sources.
Researchers examined 546 clinical drug trials conducted between 2000 and 2006 listed in the registry at www.ClinicalTrials.gov. Their analysis showed that industry funded trials reported a favorable outcome 85% of the time, compared to 50% favorable outcomes for government-funded trials and 72% favorable outcomes for trials funded by nonprofits or non-federal organizations.
Of nonprofits and non-federal studies, nearly half were the recipients of drug industry contributions and reported positive outcomes 85% of the time, while those without any such contributions reported favorable results only 61% of the time.
"While we cannot specifically point to which factors contribute to the association between funding source and positive result reporting, our findings speak to the need for more disclosure of all elements of a study," said Florence Bourgeois, MD, MPH, of Children's Hospital Boston in a news release. "Publication bias is likely a contributing factor, but there may be many more, including biases in study design, patient selection, data analysis and results reporting."
The clinical trial review entitled 'Outcome Reporting among Drug Trials Registered in ClinicalTrials.gov' by Florence T. Bourgeois, MD, MPH; Srinivas Murthy, MD; and Kenneth D. Mandl, MD, MPH appears in the August 3, 2010 issue of the Annals of Internal Medicine.
Researchers also found that drug trials funded by pharmaceutical industry were less likely to be published within 2 years of study completion.
The National Institute of Child Health and Human Development and National Library of Medicine funded the study.
The U.S Food and Drug Administration (FDA) uses results of clinical drug trials in the approval process and regulation of drugs.
Originally posted at InjuryBoard by Paul NapoliFull post as published by New York City Personal Injury Lawyer on August 02, 2010 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Truth In Lending Act
Consumer Loans and Consumer Credit Protection Act
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Delayed Diagnosis Results in $1.1M Settlement
Delayed Diagnosis Results in $1.1M Settlement>
Bank Website Security
New Report Finds Widespread Flaws
Operating Room Fires
Hundreds Injured During Surgery, New Report Shows
Oil and Gas
industry workers allegedly subject to serious accident injury from hazardous conditions.
Water Contamination
Industry giants to pay $500,000 settlement in environmental lawsuit.

Out of the U.S. No Oversight Necessary
Pharma Industry To Publish Clinical Trial Results
Limiting Liability in Clinical Trials: Non-Lawyers, Lawyers Beware
Interested in Learning More about CP Clinical Trials
Elderly often excluded from drug trials for drugs intended for them!
Pharmaceutical Law Summer School








